Xone A Tablets 5/80/10 Milligrams
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
MFDS item code 202005384 · Approved 2020.07.24 · Insurance code 640007680
Treatment of hypertension, improvement of dyslipidemia, prevention of cardiovascular diseases
This medication is used to effectively manage blood pressure in patients with hypertension who have difficulty controlling their blood pressure with amlodipine/valsartan combination therapy. Additionally, atorvastatin helps to reduce the risks of myocardial infarction, stroke, vascular surgeries, and angina in adults at risk for cardiovascular diseases, in patients with type 2 diabetes, and in those who already have coronary heart disease. Atorvastatin is also used to treat dyslipidemia, lowering total cholesterol and bad LDL cholesterol levels while increasing good HDL cholesterol levels, thereby improving vascular health. Both medications together are effective in simultaneously managing blood pressure and blood lipids and reducing the risk of cardiovascular diseases.
Take 1 tablet of this medicine once daily with water. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking an amlodipine/valsartan combination and atorvastatin as separate products may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. ▷ Amlodipine/valsartan combination It is recommended that the doses of the individual components (amlodipine or valsartan) be adjusted before administering the amlodipine/valsartan combination. However, direct conversion to the amlodipine/valsartan combination may be considered when blood pressure is not adequately controlled with monotherapy using the individual components, as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. - Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. - Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. - Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose. ▷ Atorvastatin Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. It may be taken at any time of day, with or without food. 1. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after initiation of treatment and/or dose titration, and the dose should be adjusted accordingly. Since the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used at treatment initiation and to assess response to treatment. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It should be administered in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when such lipid-lowering treatments are unavailable. - Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. - Elderly patients: The efficacy and safety in elderly patients aged 70 years or older are generally similar to those in the general adult patient population.
This medication may cause serious harm to the fetus and newborns when administered to women in the second and third trimesters of pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. If muscle-related diseases are suspected or if there is a significant increase in muscle enzyme levels in blood tests, discontinuation of this medication is necessary. This medication should not be used in individuals with specific allergic reactions, patients with severe liver or kidney diseases, or in pregnant or breastfeeding women. Monitor and observe patients with sodium or fluid depletion for the risk of hypotension before administration. Patients with elevated potassium levels should be cautious when taking this medication along with potassium supplements or medications that increase potassium, and potassium levels should be checked regularly. Patients with impaired kidney function or kidney transplant recipients should closely monitor changes in kidney function while taking this medication. If symptoms of angioedema occur, this medication should be discontinued immediately and should not be readministered. Patients with heart failure or after myocardial infarction may have an increased risk of renal function deterioration when taking this medication, thus regular evaluation is required. Caution should be exercised when using this medication in patients with impaired liver or kidney function, the elderly, or those with a history of muscle diseases, as the risk of side effects is higher. Dizziness or fatigue may occur when driving or operating machinery, so caution is advised. This medication may interact with several others, so it's essential to consult with a physician or pharmacist if taking other medications. Women who are pregnant or planning to become pregnant should consult with healthcare professionals before taking this medication and should use appropriate contraception. It's best for breastfeeding women to avoid this medication, and consult healthcare providers if necessary. If symptoms such as muscle pain, weakness, or fever occur while taking this medication, notify healthcare professionals immediately, and blood tests may be required to check for muscle damage. If symptoms of liver dysfunction (nausea, vomiting, jaundice, etc.) occur, discontinue use immediately and consult healthcare professionals. The safety of this medication has not been established in children, so caution is advised when administering it to minors.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from exposure to air and moisture. It is best to store it at room temperature between 1 and 30 degrees Celsius.
White oval film-coated tablet
Bottle - 30 Tablets/Bottle, Bottle - 100 Tablets/Bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Dongu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Dong Gu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.